Activist Radoff-JEC Group Escalates Proxy Fight, Urges Vote for New Directors Citing 97% Stock Decline & Rejected Bids
SEER is trading near its 52-week low of $1.65 (1.2% above the low).
Summary
Activist investor Radoff-JEC Group intensifies its proxy contest against Seer, releasing a detailed presentation accusing current management of severe value destruction and anti-stockholder actions, urging shareholders to vote for new independent directors at the upcoming annual meeting.
Key Events · Corporate Governance and Compliance · SEER
-
Activist Escalates Proxy Contest
The Radoff-JEC Group, holding approximately 7.7% of Seer, Inc., released a detailed presentation urging stockholders to vote for their three independent director nominees at the upcoming annual meeting on July 28, 2026.
-
Allegations of Severe Value Destruction
The group accuses current management of overseeing a 97% share price decline since the IPO, cumulative losses exceeding $465 million, minimal revenue growth, and a projected lack of profitability until 2031.
-
Criticism of CEO Compensation and Stock Sales
The filing highlights that CEO Omid Farokhzad sold over $103 million in Seer shares (exceeding the current market cap) and received nearly $37 million in compensation while the stock significantly underperformed.
-
Board's Anti-Stockholder Actions
The activist group criticizes the Board for unilaterally adopting a 'NOL pill' (poison pill) and rejecting three fully financed acquisition proposals from the Radoff-JEC Group (offering premiums of 33-42% to the unaffected share price) without engagement.
Analysis · SEER · Industrial Applications And Services
This DFAN14A filing marks a significant escalation in the ongoing proxy contest between activist investor Radoff-JEC Group and Seer's current board and management. The activist group, holding a substantial 7.7% stake, has released a comprehensive presentation detailing severe allegations of value destruction, including a 97% stock price decline since IPO, substantial operating losses, and the CEO's significant stock sales and compensation amidst poor performance. Crucially, the filing highlights the Board's rejection of multiple premium acquisition offers and the adoption of a "poison pill" as anti-stockholder actions. With the annual meeting scheduled for July 28, this direct appeal to shareholders for boardroom change, coupled with the company trading near 52-week lows and below its net cash, creates immense pressure on the current leadership and could lead to a significant shift in corporate control or strategy.
At the time of this filing, SEER was trading at $1.67 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $91.8M. The 52-week trading range was $1.65 to $2.41. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.